Azitra Inc(AZTR) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates BRANFORD, Conn. — Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the three months ended September 30, 2024 and provided a business update. Q3 2024 and Recent Business Highlights: ● Completed a follow-on offering of $10 million in gross proceeds ● Dosed first Netherton syndrome pat ...